Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation

Summary:

Osteoporosis and osteopenia affect up to half of patients with thalassaemia major (TM). We investigate the effects of acquired factors and BMT on bone mineral density (BMD) in these patients. In all, 53 patients on regular transfusion (BT group) and 33 patients at 5.7±1.9 years post transplant (BMT group) were recruited. BMD was measured by dual energy X-ray absorptiometry. Serum concentrations of osteocalcin, bone-specific alkaline phosphatase (ALP), beta-crossLap and urinary cross-linking deoxypyridinoline (DPD) were measured by chemiluminescence and enzyme immunoassay, respectively. Severe BMD deficit (Z-score <−2.5) at spine and hip were noted in 62 and 35% of BT group. Serum osteocalcin (β=−0.463; P=0.006) was predictive of spine BMD, whereas age (β=−0.843; P=0.007) and urine DPD (β=−0.439; P=0.037) were associated with hip BMD in BT group. Among BMT patients, post transplant duration (β=0.450; P=0.009) and serum bone-specific ALP (β=−0.495; P=0.013) were associated with spine BMD. Severe BMD deficit was less common among BMT than BT patients (6 vs 35%; P=0.036). The mean (s.d.) osteocalcin levels in BMT and BT groups were 96.4 (72.7) μg/l and 68.9 (40.3) μg/l, respectively (P=0.037). In conclusion, severe BMD deficit is common in Chinese TM patients and BMT may reverse BMD deficit in these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Jensen CE, Tuck SM, Agnew JE et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998; 103: 911–915.

    Article  CAS  Google Scholar 

  2. Filosa A, Di Maio S, Vocca S et al. Longitudinal monitoring of bone mineral density in thalassaemic patients: Genetic structure and osteoporosis. Acta Paediatr 1997; 86: 342–346.

    Article  CAS  Google Scholar 

  3. Wonke B, Jensen C, Hanslip JJ et al. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 1998; 11 (Suppl. 3): 795–801.

    PubMed  Google Scholar 

  4. Anapliotou ML, Kastanias IT, Psara P et al. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol 1995; 42: 279–287.

    Article  CAS  Google Scholar 

  5. Angastiniotis M, Pavlides N, Aristidou K et al. Bone pain in thalassaemia: assessment of DEXA and MRI findings. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 779–784.

    PubMed  Google Scholar 

  6. Glastre C, Braillon P, David L . Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: Correlations with growth parameters. J Clin Endocrinol Metab 1990; 70: 1330–1333.

    Article  CAS  Google Scholar 

  7. Pouilles JM, Tremollieres F, Todorovsky N, Ribot C . Precision and sensitivity of dual-energy x-ray absorptiometry in spinal osteoporosis. J Bone Miner Res 1991; 3: 13–18.

    Google Scholar 

  8. Cheng JC, Leung SS, Lee WT et al. Determinants of axial and peripheral bone mass in Chinese adolescents. Arch Dis Child 1998; 78: 524–530.

    Article  CAS  Google Scholar 

  9. Rioja L, Hany Y, Garabedian M, Cournot-Witmer G . Bone disease in children with homozygous β-thalassaemia. Bone Miner 1990; 8: 69–86.

    Article  CAS  Google Scholar 

  10. Johanson NA . Musculoskeletal problems in hemoglobinopathy. Ortho Clin North Am 1990; 21: 191–198.

    CAS  Google Scholar 

  11. Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S . Deferoxamine-induced bone dysplasia in patients with thalassemia major. Am J Roentgenol 1991; 156: 561–565.

    Article  CAS  Google Scholar 

  12. Chan YL, Pang LM, Chik KW et al. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr Radiol 2002; 32: 492–497.

    Article  Google Scholar 

  13. Li CK, Shing MM, Chik KW et al. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome. Bone Marrow Transplant 2002; 29: 101–105.

    Article  CAS  Google Scholar 

  14. Li CK, Chik KW, Wong GW et al. Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol 2004; 21: 411–419.

    Article  CAS  Google Scholar 

  15. Johnston CC, Melton III LJ, Lindsay R, Eddy D . Clinical indications for bone mass measurement. J Bone Miner Res 1989; 4: 1–28.

    Google Scholar 

  16. Gafni RI, Baron J . Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). J Pediatr 2004; 144: 253–257.

    Article  Google Scholar 

  17. Argyropoulou MI, Metafratzi Z, Kiortsis DN et al. T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major. Am J Roentgenol 2000; 175: 1567–1569.

    Article  CAS  Google Scholar 

  18. Chrysis DC, Alexandrides TK, Koromantzou E et al. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia. Clin Endocrinol (Oxford) 2001; 54: 253–259.

    Article  CAS  Google Scholar 

  19. Gulati R, Bhatia V, Agarwal SS . Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 2000; 13: 651–656.

    Article  CAS  Google Scholar 

  20. Pennisi P, Pizzarelli G, Spina M et al. Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis. J Bone Miner Metab 2003; 21: 402–408.

    Article  Google Scholar 

  21. Voskaridou E, Terpos E, Spina G et al. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Br J Haematol 2003; 123: 730–737.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Iris HS Chan and Chung Yi Li for their technical assistance in measuring biochemical bone markers.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T F Leung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leung, T., Hung, E., Lam, C. et al. Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation. Bone Marrow Transplant 36, 331–336 (2005). https://doi.org/10.1038/sj.bmt.1705053

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705053

Keywords

This article is cited by

Search

Quick links